Chizuko Onozawa

Neuritogenic Effect of Epolactaene Derivatives on Human Neuroblastoma Cells Which Lack High-Affinity Nerve Growth Factor Receptors

Hideaki Kakeya, Chizuko Onozawa, Masakazu Sato et al. · Journal of Medicinal Chemistry · 1997 · 87 citations

Tumor Innervation, Altmetric Attention Score, Cellular Pharmacology +19

Three Isoforms of Platelet-Derived Growth Factors All Have the Capability to Induce Angiogenesis in Vivo.

Tsutomu Oikawa, Chizuko Onozawa, I. Morita et al. · Biological and Pharmaceutical Bulletin · 1994 · 47 citations · Full text

Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo.

Tsutomu Oikawa, Chizuko Onozawa, Masako Inose · Biological and Pharmaceutical Bulletin · 1995 · 30 citations · Full text

RKS-1778, a New Mammalian Cell-Cycle Inhibitor and a Key Intermediate of the [11]Cytochalasin Group

Hideaki Kakeya, Masayuki Morishita, Chizuko Onozawa et al. · Journal of Natural Products · 1997 · 25 citations

Bioorganic Chemistry, Key Intermediate, Epoxycytochalasin H +20

Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic.

Hideaki Kakeya, Rie Onose, Paul C. Liu et al. · PubMed · 1998 · 20 citations

Retinoblastoma Protein, Nucleotide Antibiotic, Cell Cycle +21